Table 1 Characteristics of the study population and average results of the inferior vena cava (IVC) distensibility, minimum and maximum diameters (IVC-DI, IVC-min and IVC-max, respectively) calculated in subcostal (SC) and transhepatic (TH) windows
Baseline characteristics and measurements | Ventilatory settings and Hemodynamics | ||
|---|---|---|---|
Gender (male) | 25/32 (78%) | PEEP (cmH2O) | 6 ± 1 |
Age (years) | 65 ± 13 | Pressure Control (cmH2O) | 16 ± 6 |
Weight (Kg) | 80 ± 21 | Tidal Volume (ml) | 517 ± 124 |
Height (cm) | 170 ± 7 | Respiratory Rate (bpm) | 16 ± 3 |
SaO2 (%) | 98 ± 3 | ||
IVCmin in SC (mm, M-mode) | 20.8 ± 4.4 | Heart rate (bpm) | 83 ± 19 |
IVCmax in SC (mm, M-mode) | 23.7 ± 4.3 | Sinus rhythm (n =) | 29/32 |
IVC-DI in SC (%, M-mode) | 14.8 ± 7.9 | SAP (mmHg) | 106 ± 22 |
IVCmin in TH (mm, M-mode) | 19.8 ± 4.2 | MAP (mmHg) | 74 ± 14 |
IVCmax in TH (mm, M-mode) | 22.6 ± 4.2 | DAP (mmHg) | 58 ± 12 |
IVC-DI in TH (%, M-mode) | 15.1 ± 8.5 | PPV (%) | 13 ± 10 |
Norepinephrine (mcg/kg/min) | 0.33 ± 0.22 | ||
SOFA score | 12.2 ± 3.7 | Vasoactive (n =) | 20/32 (63%) |
Mortality | 22/32 (69%) | Second vasoactive drug (n =) | 5 (16%) |